NIH-funded research R01 grant

Understanding how cells regulate protein diversity through splicing

Official title: Engineering cell type-specific splicing regulation

Funded at University of Washington · NIH-10934322 · Data updated 2026-11-12

This study is exploring how different types of cells manage the way genes are turned into proteins, which can help us find new ways to treat diseases by fine-tuning how genes work in specific cells.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 25, 2023
Project endAugust 31, 2027
Funding year2024
Award (this year)$382,153
NIH project number5R01GM149631-02
Project IDNIH-10934322 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic disorders or diseases that could benefit from targeted gene therapies.

Less likely to help

Patients with conditions that do not involve alternative splicing or genetic alterations may not benefit from this research.

What this research studies

This research investigates how different cell types control the process of alternative splicing, which affects the diversity of proteins produced in the body. By using advanced techniques like synthetic biology and machine learning, the team aims to create specific tools that can manipulate splicing in targeted cell types. This could lead to new ways to treat diseases by activating or silencing genes in a precise manner. The research involves creating large libraries of genetic constructs to study how splicing varies across different cell types.

Why it matters

Potential benefit: If successful, this research could lead to innovative gene therapies that are tailored to specific cell types, improving treatment outcomes for various diseases.

How similar studies have gone: Previous research has shown promise in using synthetic biology and machine learning for gene regulation, indicating a potential for success in this novel approach.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Seelig, Georg — University of Washington
  • Study coordinator: Seelig, Georg

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.